Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 9.008E-15 | 1.961E-10 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 7.512E-10 | 2.337E-06 | CYP1A2, CYP2C19, CYP2C9, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 7.512E-10 | 2.337E-06 | CYP1A2, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 3.442E-09 | 5.765E-06 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4, PTGS1 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 1.057E-08 | 1.129E-05 | AKR1B1, AKR1B10, CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 1.760E-07 | 1.369E-04 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 1.934E-06 | 1.138E-03 | CYP1A2, CYP2C19, CYP2C9 |
BP | GO:0065007; biological regulation | GO:0006919; activation of cysteine-type endopeptidase activity involved in apoptotic process | 2.512E-06 | 1.436E-03 | CASP1, CASP7, MAPT, XDH |
BP | GO:0051179; localization | GO:1904823; purine nucleobase transmembrane transport | 4.066E-06 | 1.967E-03 | SLC28A1, SLC28A3 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 4.066E-06 | 1.967E-03 | CYP2D6, CYP3A4 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00040 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 7.783E-04 | 2.835E-03 | AKR1B10; AKR1B1 |
hsa00051 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 6.144E-04 | 2.410E-03 | AKR1B10; AKR1B1 |
hsa00052 | Galactose metabolism_Homo sapiens_hsa00052 | 5.396E-04 | 2.293E-03 | AKR1B10; AKR1B1 |
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.011E-03 | 5.893E-03 | CYP1A2; CYP3A4 |
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.262E-05 | 7.154E-05 | CYP1A2; XDH |
hsa00240 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 6.428E-03 | 1.639E-02 | CDA; TK1 |
hsa00561 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.080E-03 | 5.893E-03 | AKR1B10; AKR1B1 |
hsa00590 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 7.092E-07 | 6.028E-06 | CYP2C9; ALOX15; CYP2C19; PTGS1 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.472E-10 | 7.510E-09 | CYP2C9; CYP1A2; ALOX15; CYP3A4; CYP2C19 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 5.539E-05 | 2.825E-04 | CYP2C9; CYP1A2; CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Bacterial infections | A00-B99 | CYP2C9 |
A00-B99: Certain infectious and parasitic diseases | Malaria | B54 | CYP2D6 |
A00-B99: Certain infectious and parasitic diseases | Adult varicella zoster virus infection | B02 | TK1 |
C00-D49: Neoplasms | Solid tumours | C00-D48 | HIF1A; CA9; TK1; CDA |
C00-D49: Neoplasms | Brain cancer | C71, D33 | TK1 |
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | TK1 |
C00-D49: Neoplasms | Prostate cancer | C61 | TK1 |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | PTGS1 |
C00-D49: Neoplasms | Cancer | C00-C96 | HIF1A; CA9; TK1 |
C00-D49: Neoplasms | Renal cancer | C64 | CA9 |